partnering human iron

sales & marketing

Pharmacosmos works closely and actively with our partners around the world for the marketing of our IV iron products. We believe that the combination of our partners' local expertise within Sales, Marketing and Market Access combined with Pharmacosmos' deep knowledge of the international market for IV iron and the treatment of Iron Deficiency, is the foundation for a successful business and a solid long-term business relationship. Key words in the relationships with our partners are dedication, professionalism, long term relationships and mutual respect and understanding.

Apart from our partners being professional and competent within the marketing of ethical pharmaceutical products, we ask our partners to be dedicated to making Monofer a success in a close cooperation with Pharmacosmos, which entail that sufficient dedicated resources are assigned to the Monofer® business. Furthermore, the partner shoul have existing business in some of the relevant segments, typically gastroenterology, nephrology, gyn/obs, surgery and cardiovascular.


Pharmacosmos is looking for partners for Monofer® in:

  • US (Ph 3): Commercial partner. The US IV iron market is worth ~$1B (2017) with double digit growth rates and is expected to reach ~$2B by 2030. The main growth drivers are increased use of IV iron outside dialysis and transition to high-dose premium products

To learn more, please contact Michael Ryde at



We promote our products through own sales and marketing organisations in the Nordic countries, UK/Ireland  and Germany and we are looking to in-license complementary specialty care products within gastroenterology, nephrology, gyn/obs, surgery and cardiovascular.

Our focus is on complex and innovative products with IP protection and a scientific content, in registration phase or having been on the market for a number of years.

To learn more, please contact Claes Christian Stroem at


collaboration with resarchers & clinicians

We collaborate with leading medical experts in driving research to uncover new clinical insights of iron metabolism and iron deficiency that have the potential to change the way iron deficiency is prevented and treated in humans. We are actively seeking opportunities to collaborate on investigator sponsored studies.

To learn more, please contact Lars L. Thomsen at

Veterinary iron

Partnering opportunities - Veterinary Iron


Partnering opportunities - Carbohydrates